News

Depomed’s Proquin® XR, licensed for Europe to Rottapharm | Madaus, approved in Sweden
July, 2008

Rottapharm|Madaus licenses canadian rights for SANCTURA XR™ to Allergan Inc.
May, 2008

Rottapharm:

bought 100% of Madaus Pharma, German global pharmaceutical company

June, 2007

 

Rottapharm announces favourable results of a pivotal phase III trial of dexloxiglumide in irritable bowel syndrome (IBS)

May, 2007

 

GUIDE Study presented at the ECCEO6

March, 2006

Rottapharm acquires Biochimici PSN

July, 2005

Sponsorship of the installation "The Writer" by Giancarlo Neri

May, 2005

Babygella/Rottapharm wins the Federculture Award*

February, 2005

Rottapharm and Xytis enter into global licensing agreement for neboglamine

January, 2005

Il fazzoletto arancione

January, 2005

Arthritis: the Italian way

November, 2004

Rottapharm supports the project "Babygella – Insieme alla Scoperta dell’Arte"*

October, 2004

HRT at the ISGE Congress 2004

February, 2004

Glucosamine sulfate shows promise in the fight against osteoarthritis

October, 2002

Osteoarthritis: glucosamine sulfate is proved as the first drug able to stop the disease

October, 2002

Rottapharm supports the exhibition “The Ancestor”

September, 2002

Rottapharm supports the Toshimitsu Imaï Exhibition

August, 2002

IOF Congress 2002 - Life begins at 50: advice for a risk-free menopause

June, 2002

Rottapharm supports the Pompeo Mariani Exhibition

March, 2002

NAMS 2001: New Investigator Award 2001

October, 2001

EULAR Congress 2001

June, 2001

The Lancet

January, 2001

ACR 2000: Clinical study confirms previous results of Glucosamine Sulfate on joint health

November, 2000

Forest Labs announces agreement with Rotta Research for licence Dexloxiglumide

July, 2000

Rottapharm buys Guieu Labs

December, 1999

Glucosamine Sulfate reduces progression of knee osteoarthritis

October, 1999